Flow cytometry in the diagnosis in hematologic diseases. NLM AIDSLINE Important note: Information in this article was accurate in 1987. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Flow cytometry in the diagnosis in hematologic diseases.

Ann Clin Lab Sci. 1986 Nov-Dec;16(6):427-42. Unique Identifier : AIDSLINE MED/87098607
Parker JW

Abstract: Because of recent advances in instrumentation, immunological reagents, and methods for measuring a variety of cell constituents and functions, there has been increasing interest in clinical applications of flow cytometry. Several commercially available flow cytometers and a growing list of monoclonal antibodies make it feasible for clinical laboratories to apply this technology for phenotyping leukocytes in leukemias, lymphomas, immunological disorders, transplant patients, and infectious diseases. The ability to measure cell constituents such as deoxyribonucleic acid (DNA), ribonucleic acid (RNA), proteins, enzymes, and hormone receptors has added to the list of applications. Use in conjunction with simultaneous phenotyping with monoclonal antibodies makes such measurements even more valuable. Phenotyping specimens from a large number of patients with lymphomas and leukemias, the AIDS related complex, and other immunological disorders, has demonstrated the value of flow cytometry in diagnosis and patient management.
Keywords: Antibodies, Monoclonal/DIAGNOSTIC USE AIDS-Related Complex/DIAGNOSIS B-Lymphocytes Case Report Cell Cycle DNA/ANALYSIS Female Flow Cytometry/*METHODS Hematologic Diseases/*DIAGNOSIS Human Leukemia/DIAGNOSIS Lymphoma/DIAGNOSIS Male T-Lymphocytes JOURNAL ARTICLE REVIEW

KWDantibodies,monoclonal/diagnosticuseaids-relatedcomplex/diagnosisb-lymphocytescasereportcellcycledna/analysisfemaleflowcytometry/KWDmethodshematologicdiseases/KWDdiagnosishumanleukemia/diagnosislymphoma/diagnosismalet-lymphocytesjournalarticlereview
870430
M8740077

Copyright © 1987 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1987. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1987. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .